90 units of tirzepatide FDA approves a new weight loss drug, Zepbound from Eli Lilly Lilly releases Zepbound® (tirzepatide) single-dose

Topical applications also face absorption challenges, affecting only superficial skin layers rather than providing systemic benefits

Is your skin looking tired, dull, or aging faster than youd like

For patients seeking a lower entry point, PlexusDx's Microdose GLP-1 Protocol costs $129 per month flat, providing an alternative if budget constraints require a more economical option during your maintenance phase

Gastrointestinal Issues : Conditions such as diverticulitis (inflammation or infection of small pouches in the colon), constipation, trapped gas, or irritable bowel syndrome (IBS) can all result in sharp or recurrent pain in the lower left abdomen